STONY BROOK, N.Y.--(BUSINESS WIRE)--LineaRx, Inc., the majority-owned subsidiary of Applied DNA Sciences, Inc. (NASDAQ: APDN) focused on next-generation biotherapeutics, announced today that its ...
Tumor Reduction Demonstrated in Vivo Using Two Linear DNA Vaccines in Animal Models Evvivax S.R.L. designed a synthetic gene sequence to produce immunity in companion animals, directed against the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback